key: cord-0256824-tok2cyji authors: Medel Ramirez, C.; Medel-Lopez, H.; Lara-Merida, J. title: (SARS-CoV-2) COVID 19: Genomic surveillance and evaluation of the impact on the population speaker of indigenous language in Mexico date: 2021-12-11 journal: nan DOI: 10.1101/2021.12.09.21267022 sha: ad3b9115d6fe9ca2de0a31832c87b52412d91235 doc_id: 256824 cord_uid: tok2cyji The importance of the working document is that it allows the analysis of information and cases associated with (SARS-CoV-2) COVID-19, based on the daily information generated by the Government of Mexico through the Secretariat of Health, responsible for the Epidemiological Surveillance System for Viral Respiratory Diseases (SVEERV). The information in the SVEERV is disseminated as open data, and the level of information is displayed at the municipal, state and national levels. On the other hand, the monitoring of the genomic surveillance of (SARS-CoV-2) COVID-19, through the identification of variants and mutations, is registered in the database of the Information System of the Global Initiative on Sharing All Influenza Data (GISAID) based in Germany. These two sources of information SVEERV and GISAID provide the information for the analysis of the impact of (SARS-CoV-2) COVID-19 on the population in Mexico. The first data source identifies information, at the national level, on patients according to age, sex, comorbidities and COVID-19 presence (SARS-CoV-2), among other characteristics. The data analysis is carried out by means of the design of an algorithm applying data mining techniques and methodology, to estimate the case fatality rate, positivity index and identify a typology according to the severity of the infection identified in patients who present a positive result. for (SARS-CoV-2) COVID-19. From the second data source, information is obtained worldwide on the new variants and mutations of COVID-19 (SARS-CoV-2), providing valuable information for timely genomic surveillance. This study analyzes the impact of (SARS-CoV-2) COVID-19 on the indigenous language-speaking population, it allows us to provide information, quickly and in a timely manner, to support the design of public policy on health. Germany, with information provided by national health authorities in various countries, with a level of periodicity and quality in the identification of genomic variants identified worldwide. The first data source contains information, at the national, state and municipal level of patients according to age, sex, comorbidities and COVID-19 presence condition (SARS-CoV-2), among other characteristics. The data analysis is carried out through the design of an algorithm applying data mining techniques and methodology, to estimate the case fatality rate, the positivity index and identify a typology according to the severity of the infection identified in patients who present a result positive for (SARS-CoV-2) COVID-19. While from the second data source, information is obtained worldwide on the new variants and mutations of the (SARS-CoV-2) COVID- 19 , providing valuable information for timely genomic surveillance. 5 The importance of this research is its relevance in a line within the National Research and Incidence Projects (PRONAII) and Conacyt National Strategic Programs (PRONACES) 2021, which is part of the thematic Axis "Health", on the topic: "Genomic surveillance of SARS -CoV-2 ", corresponding to the subtopic:" SARS-CoV-2 metadata analysis and genomic sequencing ". 6 This study analyzes the impact of (SARS-CoV-2) COVID- 19 on the indigenous language-speaking population, allowing information to be provided, quickly and in a timely manner, to support the design of public health policy. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021. 12.09.21267022 doi: medRxiv preprint In Mexico, the genomic variants present as of September 3, 2021 are: VOC Alpha , VOC Beta , VOC Gamma , VOC Delta , VOI Eta , VOI Iota y VOI Lambda . See Graph 2 below, which shows the variants identified in the period from March 2020 to September 2021. Delta (WHO label) it is one of the variants that has shown a higher level of contagion. The (WHO, 2020) describes that the pattern of (SARS-CoV-2) COVID-19 presents four typologies depending on the severity of the intensity of contagion, these being: i) not infected or ii) infected; in this finally, four categories are identified in each case: a) mild infection, b) moderate infection, c) severe infection and d) critical infection. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Depending on the category observed in patients who are confirmed infected, as in the case of a) or b), it can assume the outpatient nature, so the strategy is isolation or "quarantine" at home, where the expected result is he recovers. Regarding patients with confirmed infection, in categories c) and d) they assume the character of hospitalized patients, with the probability of requiring care in intensive care units and requiring intubation, and where it is expected to save as many patients as possible, in the face of scarce hospital resources and a growing demand from patients who require specialized medical care services. In (Medel-Ramírez C, Medel-Lopez H, 2020) present a study through the application of data mining techniques and the design of an algorithm for the identification of indigenous language speaking patients, who have presented a positive result for (SARS -CoV-2) COVID 19 in Mexico. This study analyzes the information at the municipal, state and national level, presenting the categories of analysis related to: age, sex, present comorbidities, as well as the medical strategy used in the treatment and accounts for the deaths registered according to their degree of infection. presented by the patients. This study draws on two sources of information: a) At the national level, with information from the Epidemiological Surveillance System for Viral Respiratory Diseases (SVEERV), in charge of the Ministry of Health of Mexico; and b) At an . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint international level, with information from the Information System of the Global Initiative on Sharing All Influenza Data (GISAID) based in Germany. The Ministry of Health with the participation of the National Council of Science and Technology (CONACYT), the Center for Research in Geospatial Information Sciences (CENTROGEO), the National Geointelligence Laboratory (GEOINT), the Data Laboratory of the National Geointelligence Laboratory (DataLab), present a daily report that accounts for the presence of cases of (SARS-CoV-2) COVID-19, being this official means of communication and information on the epidemic in Mexico. 21 The information in the SVEERV is disseminated as open data and its information is presented at the municipal, state and national levels. This source of information provides the number of cases registered for (SARS-CoV-2) COVID-19 by the Ministry of Health responsible for the Epidemiological Surveillance System for Viral Respiratory Diseases (SVEERV) and comes from the website https://data.gob.mx/busca/dataset/informacion-referente-a-canes-covid-19-enmexico The second source of information is the Global Initiative on Sharing All Influenza Data (GISAID) Information System, which reports on the genomic monitoring and surveillance of (SARS-CoV-2) COVID-19, by registering and identifying variants and mutations. reported by public health organizations, diagnostic laboratories, and international public and private health institutions. 21 The information of the registered cases of (SARS-CoV-2) COVID-19 in Mexico, is concentrated daily in the Epidemiological Surveillance System of Viral Respiratory Diseases since April 19, 2020, this being the communication channel and official information on the epidemic in Mexico. The data are presented with a disaggregation at the municipal, state and national levels, taking into account the categories of age, sex, present comorbidities and associated with the presence of (SARS-CoV-2) COVID-19. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint The information processing is carried out through the design of an algorithm 22 which is built with the support of Orange Data Mining application software for data mining and visual programming 23 version 3.29.3., which is a mining suite for data analysis that uses visual programming and Python scripts. In this way, the following algorithms have been designed for the study of (SARS-CoV-2) COVID Next, the sections that give an account of the methodological structure for the construction of the algorithms using data mining techniques for the analysis of the impact and genomic monitoring of (SARS-CoV-2) COVID-19 in Mexico are presented. With the data source that comes from the information registered by the Ministry of Health of Mexico, and that is presented as open data (open-data), in comma 22 The design of the data mining algorithm presented below is made up of the definitions, heuristic conditions and calculations by which the model for the analysis of the information is built to know the impact of the (SARS-CoV-2) COVID-19) in Mexico. The structure is presented in pseudo code, which uses visual programming and Python scripts. TP SARS-CoV-2 I j = (P + SARS-CoV-2 I j) + (P -SARS-CoV-2 I j) + (P x SARS-CoV-2 I j ) where: I = state, j = municipality. 24 According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 3) to identify suspected cases of (SARS-CoV-2) COVID-19. A patient assumes the category of suspect for (SARS-CoV-2) COVID-19 if the diagnostic characteristics indicated by the World Health Organization present the following considerations. Let: Px SARS-CoV-2 ij = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID-19, where: Px SARS-CoV-2 ij = Px (SARS-CoV-2) COVID-19 Type 1 + Px (SARS-CoV-2) COVID-19 Type 2 + Px (SARSCoV-2) COVID-19 Type 3. Identifying the following scenarios: 1. Px (SARS-CoV-2) COVID-19 Type 1.-Confirmed by association applies when the case reported being a positive contact for COVID-19 (and this is registered in the SISVER) and the case is not I took a sample or the sample was invalid. 2. Px (SARS-CoV-2) COVID-19 Type 2.-Confirmed by ruling only applies to deaths under the following conditions: The case was not sampled or a sample was taken, but the sample was invalid. 3. Px (SARS-CoV-2) COVID-19 Type 3.-Confirmed applies when: The case has a laboratory sample or antigenic test and was positive for SARS-CoV-2, regardless of whether the case has a clinical epidemiological association. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Then: 25 The care of P + SARS-CoV-2 ICU i j, depending on the severity of the infection, can access two care scenarios: . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Be: CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The Ministry of Health of Argentina defines that VOI corresponds to "… a SARS-CoV-2 isolate is a VOI if it phenotypically behaves differently from a reference or its genome presents mutations that lead to amino acid changes associated with established phenotypic changes", and "If multiple COVID cases, clusters, or has been detected in multiple countries have been . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint Graph 3 shows that the VOC Delta and VOC Gamma variants have an important presence in the national territory. It should be noted that the VOC Delta variant is one of the most variants that presents a higher level of contagion, and therefore, it is more careful. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 8 , at the end of the document). Table 4 ). Table 5 ). Table 6 ). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 7 ). 9 . Figure 3 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; As an indicator of the hospital medical care strategy, considering the level of symptoms and severity present in indigenous-language speaking patients, only 30.68% received hospital medical care. It is important to highlight that men are the largest number of patients treated in this modality, representing 58.43% while women correspond to 41.57%. The presence of (SARS-CoV-2) COVID-19 in Mexico, taking into account the age, sex and comorbidities present in indigenous-language speaking patients who have This situation invites us to reflect on the impact that the (SARS-CoV-2) COVID-19 in the localities that are located in these states, since the presence of hospital care centers Covid 19, are mainly found in the cities that have a greater infrastructure for . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint regional care, as is the case of urban centers, mainly. And on the other hand, it is important to note that in Mexico the presence of variants of (SARS-CoV-2) COVID-19 has been registered, the variant being VOC i j Delta = [Delta (WHO label) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint It is highlighted that the population that speaks an indigenous language, at the national level as of September 3, 2021, the number of cases that have been treated in Intensive Care Units and that required breathing support through intubation are relatively few, that is, only 358. Why is the number of people served for this sector of the population significantly lower? An approximation to the answer may be that the registry of indigenous language speaking patients, contained in the Epidemiological Surveillance System for Viral Respiratory Diseases (SVEERV), requires precisely that, to be cared for in a hospital unit for the care of (SARS -CoV-2) COVID-19, and as has been indicated, the location of the care centers, the distance from the localities with an indigenous speaking population and the speed with which the transfer is required, are factors that limit access to health care services, and on the other hand, make more evident the lack of medical infrastructure near their population centers, thus increasing the inequality and marginalization suffered by these population centers. And it is here, where in the presence of (SARS-CoV-2) COVID- 19 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint Annexes Table 1 Indigenous language speaking patients at the national level, according to result for (SARS-CoV-2) COVID-19 until September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Table 2 Indigenous language-speaking patients nationwide, according to a positive result for (SARS-CoV-2) COVID-19 as of September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Table 3 Indigenous language-speaking patients nationwide with a positive result for (SARS-CoV-2) COVID-19 according to the Medical Treatment Strategy until September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Table 5 Indigenous-language speaking patients with a positive result for (SARS-CoV-2) COVID-19 that required intubation, according to sex as of September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Table 6 Deaths of patients who speak an indigenous language with a positive result for (SARS-CoV-2) COVID-19, by sex as of September 3, 2021 Source: Own elaboration with information as of September 3, 2021 Table 7 Deaths of patients who speak an indigenous language with a positive result for (SARS-CoV-2) COVID-19 that required attention in the Intensive Care Unit, according to sex as of September 3, 2021 Fuente: Elaboración propia con información al 3 de septiembre de 2021 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint Table 8 Source: Own elaboration with information from the Information System of the Global Initiative on Sharing All Influenza Data (GISAID), as of September 3, 2021 Table 9 Genomic . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint Source: Own elaboration with information from the Information System of the Global Initiative on Sharing All Influenza Data (GISAID), as of September 3, 2021. Source: Own elaboration with information from the Information System of the Global Initiative on Sharing All Influenza Data (GISAID), as of September 3, 2021. in selected states by age groups and sex as of September 3, 2021 Source: Own elaboration with information from the Information System of the Global Initiative on Sharing All Influenza Data (GISAID), as of September 3, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2021. ; https://doi.org/10.1101/2021.12.09.21267022 doi: medRxiv preprint At present, new genomic variants of the virus have been registered, identified in priority variants 10 (VOC) and variants of interest 11 (VOI) for the first time in Colombia According to the classification of the Ministry of Health of Argentina, the priority variant identified as (VOC): a) is identified by an increase in transmission and a greater number of cases in a region, b) is identified by an increase in the transmission of contagion or c) is identified by reducing the capacity of control measures, diagnostics or vaccines See. Argentine Ministry of Health (2021) COVID 19 Current situation of the new SARS-CoV-2 variants Emerging SARS-CoV-2 Variants Open access to epidemic and pandemic virus data Open access to epidemic and pandemic virus data Global initiative on sharing all influenza data Global initiative on sharing all influenza data Global initiative on sharing all influenza data Global initiative on sharing all influenza data Centros para el control y la prevención de enfermedades Clasificaciones y definiciones de las variantes del SARS-CoV-2 Orange: Data Mining Toolbox in Python Global Initiative on Sharing All Influenza Data (GISAID) (2021) Genomic epidemiology of hCoV-19 Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de la enfermedad respiratoria viral Secretaria de Salud. Bases de datos Covid-19 México División política municipal, 1:250000 Covid-19 Éléments de littérature scientifique Bibliographie thématique Septembre 2020. Centre de documentation del L'Institut de recherche et documentation en économie de la santé (Irdes), France El (SARS-CoV-2) COVID 19 y su presencia en las zonas de hablantes de lengua indígenas en el Estado de Veracruz Data mining for the study of the Epidemic (SARS-CoV-2) COVID-19: Algorithm for the identification of patients speaking the native language in the Totonacapan area -Mexico Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Huasteco from theTantoyuca Area -Mexico Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Nahuatl from the Pajapan Zone Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Nahuatl of the Zongolica Zone Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Otomi of the Ixhuatlan de Madero area Data Mining for the Study of the Epidemic (SARS-CoV2) COVID-19: Algorithm for the Identification of Patients (SARS-CoV-2) COVID 19 in Mexico COVID 19 Situación actual de las nuevas variantes SARS-CoV-2. Informe técnico Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera Novel SARS-CoV-2/COVID 19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis ¿Cuáles son y en qué fase están las posibles vacunas contra la COVID 19 Información referente a casos COVID-19 en México Software Orange Data Mining version 3 Coronaviruses: A Historical Perspective Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. Interim guidance Genomic sequencing of SARS-CoV-2. A guide to implementation for maximum impact on public health